Prosecution Insights
Last updated: October 02, 2026
Application No. 18/294,145

CURABLE RESIN COMPOSITION, CURED PRODUCT, ELECTRONIC COMPONENT, OPTICAL COMPONENT, AND COMPOSITE MEMBER

Non-Final OA §102§112
Filed
Jan 31, 2024
Priority
Aug 11, 2021 — JP 2021-131057 +1 more
Examiner
WHITELEY, JESSICA
Art Unit
Tech Center
Assignee
JNC Corporation
OA Round
1 (Non-Final)
89%
Grant Probability
Favorable
1-2
OA Rounds
0m
Est. Remaining
96%
With Interview

Examiner Intelligence

Grants 89% — above average
89%
Career Allowance Rate
1359 granted / 1533 resolved
+28.6% vs TC avg
Moderate +7% lift
Without
With
+7.0%
Interview Lift
resolved cases with interview
Fast prosecutor
1y 11m
Avg Prosecution
31 currently pending
Career history
1560
Total Applications
across all art units

Statute-Specific Performance

§101
1.5%
-38.5% vs TC avg
§103
33.4%
-6.6% vs TC avg
§102
34.0%
-6.0% vs TC avg
§112
18.4%
-21.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1533 resolved cases

Office Action

§102 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1, 2, 3, 5, 8, 9, and 11 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claims 4, 6-7, 10, and 12-21 depend either directly or indirectly from the above claims and, therefore, are also rejected. Claims 1, 2, 3, 5, 8, 9, and 11 recite terms in parenthesis such as in claim 1, the term “(R1 is independently…a binding part)”, wherein, the inclusion of a term within parentheses renders the claim indefinite because it is unclear whether the included term is part of the claimed invention. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1-20 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Hiraki et al (US 2018/0258323). With regards to claims 1-3 and 8-9, Hiraki teaches a curable resin composition (0012) that contains a silicone based compound having the following structure: PNG media_image1.png 125 205 media_image1.png Greyscale (0081) wherein PNG media_image2.png 200 276 media_image2.png Greyscale (0082) and X is one of the following compounds: PNG media_image3.png 208 287 media_image3.png Greyscale PNG media_image4.png 195 263 media_image4.png Greyscale (0085) and an iron compound initiator (0107). With regards to claim 4, Hiraki teaches the addition of a crosslinking agent (0077). With regards to claims 5, 10, and 11, Hiraki teaches the crosslinking agent to include trimelitic acid (-OH) (0078). With regards to claims 6 and 12, Hiraki teaches the addition of a curing catalyst (0004). With regards to claims 7 and 13, Hiraki teaches the addition of an aluminum complex (0108). With regards to claim 14, Hiraki teaches the curable resin composition to be cured to form a cured product (0046). With regards to claims 15 and 17-20, Hiraki teaches the composition to be used for an electronic product (0200). With regards to claim 16, Hiraki teaches the composition to be used due to its optical properties (0218). Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to JESSICA WHITELEY whose telephone number is (571)272-5203. The examiner can normally be reached 8 - 5:00. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Joseph Del Sole can be reached at 5712721130. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /JESSICA WHITELEY/ Primary Examiner, Art Unit 1763
Read full office action

Prosecution Timeline

Jan 31, 2024
Application Filed
Aug 11, 2026
Non-Final Rejection mailed — §102, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12748349
PHOTOSENSITIVE RESIN COMPOSITION AND DISPLAY DEVICE INCLUDING THE SAME
3y 10m to grant Granted Sep 29, 2026
Patent 12747363
ACTIVE ENERGY RAY-CURABLE INKJET INK COMPOSITION
3y 4m to grant Granted Sep 29, 2026
Patent 12741414
PARTICULATE BUILD MATERIALS FOR THREE-DIMENSIONAL PRINTING
3y 6m to grant Granted Sep 22, 2026
Patent 12735380
SYNTHESIS OF PARA-ALKYLATED SYRINGYL (METH)ACRYLATE DERIVATIVES AND PHOTOPOLYMERIZABLE COMPOSITIONS FOR ADDITIVE MANUFACTURING IN DENTAL APPLICATIONS
3y 8m to grant Granted Sep 15, 2026
Patent 12735381
CARDANOL-BASED REACTIVE DILUENTS AND THEIR USE AND PREPARATION
3y 0m to grant Granted Sep 15, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
89%
Grant Probability
96%
With Interview (+7.0%)
1y 11m (~0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1533 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month